IMR Press / CEOG / Volume 44 / Issue 1 / DOI: 10.12891/ceog3334.2017

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Resolution of hydrops fetalis caused by atrioventricular block: good postnatal evolution with terbutaline treatment
Show Less
1 Department of Obstetrics and Gynaecology, Valme University Hospital, Seville, Spain
2 Pediatric Cardiology and Pediatric Cardiac Surgery Department, Virgen del Rocío University Children´s Hospital, Seville, Spain
Clin. Exp. Obstet. Gynecol. 2017, 44(1), 154–156; https://doi.org/10.12891/ceog3334.2017
Published: 10 February 2017
Abstract

Introduction: Complete atrioventricular block (CAVB) is rarely seen, as it occurs in only 1:11 000 to 1:20 000 newborns. There is a serious risk of mortality in CAVB, mainly in those cases associated with hydrops, fetal cardiac frequency ≤ 55 beats/minute, and premature delivery. Case Report: Case of complete atrioventricular block with a poor prognosis (hydrops fetalis and foetal cardiac frequency < 5 beats/minute) caused by anti-La and anti-Ro antibodies. Intrauterine symptoms improved after treatment with terbutaline, permitting foetal viability and successful postnatal treatment with a cardiac pacemaker. Discussion: In case of complete atrioventricular block of cause autoimmune with poor prognosis should be treated with positive inotropic drugs, anticholinergics or b-mimetic in the attempt to maintain adequate ventricular frequency, and thus prevent hydrops fetalis from occurring.
Keywords
Congenital atrioventricular block
Terbutaline
Fetal arrhythmias
Fetal cardiology
Hydrops fetalis
Share
Back to top